RoB 2: a revised tool for assessing risk of bias in randomised trials - PubMed (original) (raw)
Comment
doi: 10.1136/bmj.l4898.
Jelena Savović 3 4, Matthew J Page 5, Roy G Elbers 3, Natalie S Blencowe 3 2, Isabelle Boutron 6 7 8, Christopher J Cates 9, Hung-Yuan Cheng 3 2, Mark S Corbett 10, Sandra M Eldridge 11, Jonathan R Emberson 12, Miguel A Hernán 13, Sally Hopewell 14, Asbjørn Hróbjartsson 15 16 17, Daniela R Junqueira 18, Peter Jüni 19, Jamie J Kirkham 20, Toby Lasserson 21, Tianjing Li 22, Alexandra McAleenan 3, Barnaby C Reeves 2 23, Sasha Shepperd 24, Ian Shrier 25, Lesley A Stewart 10, Kate Tilling 3 2 26, Ian R White 27, Penny F Whiting 3 4, Julian P T Higgins 3 2 4
Affiliations
- PMID: 31462531
- DOI: 10.1136/bmj.l4898
Free article
Comment
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A C Sterne et al. BMJ. 2019.
Free article
No abstract available
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi\_disclosure.pdf and declare: support from the MRC and Wellcome Trust for the submitted work; JACS reports grants from the MRC and NIHR during the conduct of the study; JS reports grants from the MRC, Cochrane Collaboration, and NIHR during the conduct of the study; CJC is one of the coordinating editors of Cochrane Airways and has responsibility for training Cochrane authors in the UK in Cochrane methodology (including the assessment of risks of bias); JRE reports grants from the MRC and Boehringer Ingelheim, outside the submitted work; MAH reports grants from the National Institutes of Health (NIH) during the conduct of the study; PJ serves as an unpaid member of the steering group of cardiovascular trials funded by Astra Zeneca, Biotronik, Biosensors, St Jude Medical, and The Medicines Company, has received research grants to the institution from Astra Zeneca, Biotronik, Biosensors International, Eli Lilly, and The Medicines Company, and honorariums to the institution for participation in advisory boards from Amgen, but has not received personal payments by any pharmaceutical company or device manufacturer; JJK reports personal fees from BMJ outside the submitted work; TLa is an employee of Cochrane; TLi reports grants from the NIH National Eye Institute, and the Patient-Centered Outcomes Research Institute during the conduct of the study; AM reports grants from MRC and Cancer Research UK during the conduct of the study; KT reports grants from MRC during the conduct of the study and personal fees from CHDI outside the submitted work; JPTH reports grants from the MRC and Cochrane Collaboration during the conduct of the study; the authors declare no other relationships or activities that could appear to have influenced the submitted work.
Comment on
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. Higgins JP, et al. BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928. BMJ. 2011. PMID: 22008217 Free PMC article.
Similar articles
- Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.
Barcot O, Boric M, Poklepovic Pericic T, Cavar M, Dosenovic S, Vuka I, Puljak L. Barcot O, et al. BMC Med Res Methodol. 2019 Aug 5;19(1):170. doi: 10.1186/s12874-019-0804-y. BMC Med Res Methodol. 2019. PMID: 31382898 Free PMC article. - Practicalities of using a modified version of the Cochrane Collaboration risk of bias tool for randomised and non-randomised study designs applied in a health technology assessment setting.
Robertson C, Ramsay C, Gurung T, Mowatt G, Pickard R, Sharma P; UK Robotic Laparoscopic Prostatectomy HTA Study Group. Robertson C, et al. Res Synth Methods. 2014 Sep;5(3):200-11. doi: 10.1002/jrsm.1102. Epub 2013 Nov 14. Res Synth Methods. 2014. PMID: 26052846 - Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews.
Puljak L, Ramic I, Arriola Naharro C, Brezova J, Lin YC, Surdila AA, Tomajkova E, Farias Medeiros I, Nikolovska M, Poklepovic Pericic T, Barcot O, Suarez Salvado M. Puljak L, et al. J Clin Epidemiol. 2020 Jul;123:114-119. doi: 10.1016/j.jclinepi.2020.03.019. Epub 2020 Apr 1. J Clin Epidemiol. 2020. PMID: 32247026 - The risk of bias of animal experiments in implant dentistry: a methodological study.
Faggion CM Jr, Diaz KT, Aranda L, Gabel F, Listl S, Alarcón MA. Faggion CM Jr, et al. Clin Oral Implants Res. 2017 Jul;28(7):e39-e45. doi: 10.1111/clr.12852. Epub 2016 Apr 16. Clin Oral Implants Res. 2017. PMID: 27083336 Review. - The Conduct and Reporting of Child Health Research: An Analysis of Randomized Controlled Trials Published in 2012 and Evaluation of Change over 5 Years.
Gates A, Hartling L, Vandermeer B, Caldwell P, Contopoulos-Ioannidis DG, Curtis S, Fernandes RM, Klassen TP, Williams K, Dyson MP. Gates A, et al. J Pediatr. 2018 Feb;193:237-244.e37. doi: 10.1016/j.jpeds.2017.09.014. Epub 2017 Nov 21. J Pediatr. 2018. PMID: 29169611 Review.
Cited by
- Potential types of bias when estimating causal effects in environmental research and how to interpret them.
Konno K, Gibbons J, Lewis R, Pullin AS. Konno K, et al. Environ Evid. 2024 Feb 7;13(1):1. doi: 10.1186/s13750-024-00324-7. Environ Evid. 2024. PMID: 39294842 - Implications of neuromuscular electrical stimulation on gait ability, balance and kinematic parameters after stroke: a systematic review and meta-analysis.
Chen S, Gao J, Zhou Y, Zheng B, Liu Y, Cao M, Huang H, Su X, Chen J. Chen S, et al. J Neuroeng Rehabil. 2024 Sep 18;21(1):164. doi: 10.1186/s12984-024-01462-2. J Neuroeng Rehabil. 2024. PMID: 39294678 Review. - The Overflow Effects of Movement Behaviour Change Interventions for Children and Adolescents: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Feng J, Huang WY, Zheng C, Jiao J, Khan A, Nisar M, Wong SH. Feng J, et al. Sports Med. 2024 Sep 18. doi: 10.1007/s40279-024-02113-1. Online ahead of print. Sports Med. 2024. PMID: 39292361 - The Efficacy of Renal Denervation in Treating Resistant Hypertension: A Systematic Review.
Azeez GA, Thirunagari M, Fatima N, Anand A, Palvia AR, Kaur A, Nassar ST. Azeez GA, et al. Cureus. 2024 Aug 16;16(8):e67007. doi: 10.7759/cureus.67007. eCollection 2024 Aug. Cureus. 2024. PMID: 39286705 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
- MC_UU_12023/21/MRC_/Medical Research Council/United Kingdom
- MR/K025635/1/MRC_/Medical Research Council/United Kingdom
- UG1 EY020522/EY/NEI NIH HHS/United States
- MR/L004933/1/MRC_/Medical Research Council/United Kingdom
- MR/J004855/1/MRC_/Medical Research Council/United Kingdom
- G0701659/MRC_/Medical Research Council/United Kingdom
- DRF-2011-04-016/DH_/Department of Health/United Kingdom
- MC_UU_00011/3/MRC_/Medical Research Council/United Kingdom
- MR/M025209/1/MRC_/Medical Research Council/United Kingdom
- MR/S001751/1/MRC_/Medical Research Council/United Kingdom
- MR/K025643/1/MRC_/Medical Research Council/United Kingdom
- MR/L004933/2/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources